… human thyroid cancers. We detected BRAF mutation, V599E, in four of six human thyroid
cancer cell lines and in 51 of 207 thyroid tumor tissues. The correlation analysis using various …

… BRAF mutation represents the most common oncogenic event in sporadic papillary thyroid
cancer (PTC). There are, however, significant discrepancies regarding the overall frequency …

… the most common genetic alteration found in papillary thyroid cancer (PTC). Recent studies
… Also, we found a somewhat higher rate of BRAF mutation in advanced stage PTC [138/191 (…

… papillary thyroid carcinoma (PTC) and Hashimoto's thyroiditis (HT) and to evaluate the
association of the BRAF mutation … The BRAF mutation V599E in papillary thyroid carcinoma (PTC) …

… of the BRAF mutation in our cohort of papillary thyroid cancer patients was 56%. BRAF
mutation-positive tumours were associated with a more locally advanced disease, and these …

… Oler G, Ebina KN, Michaluart P Jr, Kimura ET & Cerutti J 2005 Investigation of BRAF mutation
in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a …

… BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its role in PTC-…
Because overall mortality in PTC is low and the association was not independent of tumor …

… cases of thyroid carcinoma to investigate … BRAF mutation is sufficient to activate the
RAS-mediated mitogenic signaling, and thus RAS mutation is not observed in papillary carcinoma …

… , and classic papillary histology remained independently predictive of the BRAF mutation on
… The significant association between the BRAF mutation and the classic papillary histologic …

… high prevalence in melanoma and papillary thyroid carcinoma (PTC). … thyroid lesions. In
order to unravel whether there is any association between the occurrence of the BRAF mutation …